This federal Project Grant award in the amount of $747,507 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports an evaluation of an engineered calpain activity nanosensor in a mouse model of traumatic brain injury (TBI) at the University of California, San Diego (UCSD). The objective of the research is to advance the development of innovative technologies for monitoring and assessing traumatic brain injuries,...
The University of California, San Diego (UCSD) was awarded a $789,987.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on August 1, 2023 with a completion date of July 31, 2026, will support research on CTL-tolerant melanoma persister cells. The research aims to transform health care for Service Members and the American public through innovative and impactful research, and to investigate...
The University of California, San Diego (UCSD) was awarded a $1,184,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCSD's project "QUANTITATIVE ADVANCED DIFFUSION MRI FOR RELIABLE DETECTION AND ENHANCED TREATMENT OF HIGH-GRADE PROSTATE CANCER" from July 1, 2023 to June 30, 2027. Through this funding, UCSD will conduct research to advance the detection and treatment of high-grade prostate...
The University of California, San Diego (UCSD) was awarded a $1,218,012 Project Grant from the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "GERMLINE INFLUENCE ON PROSTATE CANCER METASTASIS AND TREATMENT RESPONSE." The research aims to transform health care for Service Members and the American public by investigating medical solutions for the battlefield through innovative and impactful...
The University of California, San Diego (UCSD) has been awarded a $316,000.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). This two-year award, effective from February 1, 2024 to January 31, 2026, will support research to investigate "POSTVIRAL DYNAMICS AND DYSFUNCTION OF THE AUTONOMIC NERVOUS SYSTEM VIA ADHERENCE-INDEPENDENT LONGITUDINAL CARDIOPULMONARY MONITORING." The Military Medical...
The University of California, San Diego (UCSD) has been awarded a $593,241 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund research to identify a new therapeutic target to prevent metastasis in pancreatic cancer. The three-year project, running from July 1, 2023 to June 30, 2026, leverages UCSD's expertise in cognitive science, computer science, and neuroscience to advance artificial intelligence...
The University of California, San Diego (UCSD) was awarded a $551,207.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to research a new therapeutic target to prevent pancreatic cancer metastasis. The 3-year grant period runs from July 1, 2023 to June 30, 2026. The project aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research in areas like cancer...
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $361,931 to the University of California, San Diego (UCSD) to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder, with the goal of discovering new targeted therapies. The award period runs from September 30, 2024 to September 29, 2027. UCSD, a leading academic research institution, will leverage its expertise in...
The University of California, San Diego (UCSD) has been awarded a $500,634.00 Cooperative Agreement from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 2-year project from September 1, 2023 to August 31, 2025 to research the screening and early detection of testicular germ cell tumors using serum microRNAs. As a leading public research university, UCSD will leverage its expertise across disciplines such as medicine,...
This Project Grant award, valued at $592,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the development of a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy" at the University of California, San Diego (UC San Diego). The research aims to advance innovative biomedical solutions for military service members and the broader public. UC San Diego, a leading...